Key Points
- Alloyed raised £37 million in a Series B round completed in March 2025, led by SPARX Asset Management and the Development Bank of Japan.
- YASA, a Mercedes-Benz subsidiary since 2021, opened what it describes as the UK's first axial-flux super factory in Oxfordshire in 2025.
- Moderna manufactures its mRNA vaccine at its Harwell Innovation and Technology Centre.
Oxfordshire's advanced manufacturing base spans precision engineering, electric powertrains and life sciences production — anchored by two of the county's best-known University of Oxford spinouts.
Alloyed: £37 million to scale additive manufacturing
Alloyed, founded in 2017 and headquartered in Abingdon, designs and manufactures advanced metal alloys and components using automated additive manufacturing. Its customer base includes Boeing, Microsoft, Anglo American and BMW.
In March 2025, the company completed a £37 million Series B round led by Japanese investors SPARX Asset Management and the Development Bank of Japan, with participation from Aviva Investors and Germany's Future Industry Ventures, alongside existing backers JX Advanced Metals, Anglo American and Oxford Science Enterprises. The capital is funding expanded manufacturing capacity in Abingdon and Seattle.
YASA: from Oxford PhD to Mercedes-Benz subsidiary
YASA, founded in Oxford in 2009 as a University of Oxford spinout, designs and manufactures axial-flux electric motors for automotive, marine and aerospace applications. Mercedes-Benz acquired YASA in 2021, and the company continues to operate under its own brand and from its Oxfordshire base as a wholly owned subsidiary.
In 2024, YASA entered an electric drive partnership with Automobili Lamborghini, beginning with the Revuelto V12 hybrid hypercar and continuing with the Temerario, which uses three YASA motors. In 2025, following a £12 million investment, YASA opened what it describes as the UK's first axial-flux “super factory” in Oxfordshire. Its spinout Evolito is applying the same core motor technology to electric flight.
Life sciences production
Moderna also manufactures its mRNA vaccine at its Harwell Innovation and Technology Centre, adding a life sciences dimension to the county's manufacturing base.
More in this series
UK Inward Investment Guides: Oxfordshire
Every figure, date and monetary amount in this series is drawn from a company announcement, regulatory filing or independent business press coverage. Companies and institutions named here appear as editorial information only: inclusion does not indicate sponsorship, partnership, endorsement or participation in the UK Family Office Summit.